Understanding Biomedical Innovation

The headlines are once again fixated on healthcare in the United States. Who has access to it, how much it costs, and who pays for it are the subjects of bitter political and legislative battles. Healthcare is a complex and contentious topic that has shaped political debate for many years, and will continue to do so for the foreseeable future.

Cost is a central factor in healthcare provision. Increased pressure on domestic discretionary spending has intensified the national debate about drug pricing and the cost of healthcare in general. Scientific and technological advances can help improve outcomes and reduce costs, but that innovation comes with its own high costs. Are there opportunities for using policy to reconfigure incentives for innovation and bring down the expense of drug development? Can policy better align investments with positive health outcomes? What does this mean for the future of American healthcare?

Dr. Robert Cook-Deegan has spent nearly three decades considering these questions. The author of the essential account of the Human Genome Project, The Gene Wars: Science, Politics, and the Human Genome, Professor Cook-Deegan’s research is currently focused on gene patenting and health research policy. Join him at our next New Tools breakfast seminar to discuss the critical role biomedical innovation plays in the healthcare debate.

Date
March 21, 2017
Run time
1:06:59
Location:
ASU Washington Center
Presented by:
Consortium for Science, Policy & Outcomes